Plamumab 40mg Injection
By Plamumab
Rx
1 Injection in a Vial

Composition
Adalimumab(40mg)

Manufacturer - Cipla Ltd
Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai-400013

Expires on or after
April, 2026

liver
Limited information is currently accessible regarding the utilization of Plamumab 40mg Injection in individuals with liver conditions. It is strongly recommended to seek advice from your healthcare provider before using this medication to ensure its safety and efficacy for patients with liver issues.

kidney
There is limited information on using Plamumab 40mg Injection in patients with kidney disease. Please consult your doctor for guidance.

alcohol
When using Plamumab 40mg Injection, consuming alcohol does not lead to harmful side effects. This means it is generally safe to drink alcohol while taking this medication.

driving
Caution should be taken when driving after using Plamumab 40mg Injection, as it can cause room spinning sensation and vision disturbances that may impact your ability to drive safely.

pregnancy
Plamumab 40mg Injection is likely safe in pregnancy based on animal studies with minimal harm to the baby. Limited human data is available.

breastfeeding
Plamumab 40mg Injection is likely safe during breastfeeding with limited human data showing no significant risk to the baby.
Habit Forming | No |
Chemical Class | Monoclonal Antibody |
Therapeutic Class | - |
Action Class | Disease Modifying Anti-Rheumatoid Drugs (DMARDs)- Biologics |
₹8811.5
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 01-Oct-2024